• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受骨髓移植患者的化疗引起的手足红斑。

Chemotherapy-induced acral erythema in patients receiving bone marrow transplantation.

作者信息

Crider M K, Jansen J, Norins A L, McHale M S

出版信息

Arch Dermatol. 1986 Sep;122(9):1023-7.

PMID:3527075
Abstract

Chemotherapy-induced acral erythema is an uncommon and distinctive syndrome of intense macular erythema of the palms and fingers seen in patients treated with high-dose chemotherapy. It is painful, may form bullae, and heals uneventfully with desquamation. The incidence (35%) of this complication in patients receiving bone marrow transplantation at our institution is quite high and probably reflects the exceptional doses of chemotherapy and concomitant total body irradiation these patients receive. Biopsy specimens showed vacuolar change, spongiosis, necrotic keratinocytes, and epidermal atypia. These findings probably result from direct toxic effect and mimic those of acute graft-vs-host disease. Awareness of chemotherapy-induced acral erythema is important to avoid its misdiagnosis as a cutaneous sign of acute graft-vs-host disease. This distinction can usually be made on clinical grounds. If necessary, serial skin biopsy specimens are helpful.

摘要

化疗引起的手足红斑是一种罕见且独特的综合征,表现为接受大剂量化疗的患者手掌和手指出现强烈的斑状红斑。它会引起疼痛,可能形成水疱,并在脱屑后顺利愈合。在我们机构接受骨髓移植的患者中,这种并发症的发生率(35%)相当高,这可能反映了这些患者接受的化疗剂量极高以及同时进行的全身照射。活检标本显示有空泡改变、海绵形成、坏死的角质形成细胞和表皮异型性。这些发现可能是直接毒性作用的结果,与急性移植物抗宿主病的表现相似。认识到化疗引起的手足红斑对于避免将其误诊为急性移植物抗宿主病的皮肤表现很重要。这种区分通常可以基于临床依据做出。如有必要,连续的皮肤活检标本会有所帮助。

相似文献

1
Chemotherapy-induced acral erythema in patients receiving bone marrow transplantation.接受骨髓移植患者的化疗引起的手足红斑。
Arch Dermatol. 1986 Sep;122(9):1023-7.
2
Chemotherapy-induced acral erythema and acute graft-versus-host disease after allogeneic bone marrow transplantation.化疗引起的手足红斑和异基因骨髓移植后的急性移植物抗宿主病。
Bone Marrow Transplant. 1992 Aug;10(2):185-7.
3
[Acral erythema after allogeneic graft of the bone marrow].[异基因骨髓移植后的肢端红斑]
Ann Dermatol Venereol. 1993;120(3):219-22.
4
Acral erythema during bone marrow transplantation: a case study.骨髓移植期间的肢端红斑:病例报告
Oncol Nurs Forum. 1989 Nov-Dec;16(6):829-31.
5
Intravenous immunoglobulin in the treatment of severe methotrexate-induced acral erythema.静脉注射免疫球蛋白治疗甲氨蝶呤所致严重手足红斑。
J Pediatr Hematol Oncol. 2008 May;30(5):391-3. doi: 10.1097/MPH.0b013e318168e77c.
6
[Chemotherapy-induced acral erythema: a clinical and histopathologic study of 44 cases].[化疗引起的手足红斑:44例临床及组织病理学研究]
Actas Dermosifiliogr. 2008 May;99(4):281-90.
7
Chemotherapy-induced acral erythema in a pediatric patient with acute monoblastic leukemia.
Pediatr Hematol Oncol. 2008 Apr-May;25(3):211-5. doi: 10.1080/08880010801938157.
8
Chemotherapy-induced acral erythema: desquamating lesions involving the hands and feet.
Ann Plast Surg. 1989 Sep;23(3):263-5. doi: 10.1097/00000637-198909000-00012.
9
Methotrexate-induced bullous acral erythema in a child.
J Am Acad Dermatol. 2005 May;52(5 Suppl 1):S93-5. doi: 10.1016/j.jaad.2004.11.065.
10
Toxic erythema of palms and soles associated with high-dose mercaptopurine chemotherapy.与高剂量巯嘌呤化疗相关的掌跖毒性红斑
Arch Dermatol. 1986 Dec;122(12):1413-4.

引用本文的文献

1
Vascular endothelial growth factor (VEGF) antibody significantly increases the risk of hand-foot skin reaction to multikinase inhibitors (MKIs): A systematic literature review and meta-analysis.血管内皮生长因子(VEGF)抗体显著增加了手足皮肤对多激酶抑制剂(MKIs)产生反应的风险:一项系统文献综述与荟萃分析。
Clin Exp Pharmacol Physiol. 2018 Jul;45(7):659-667. doi: 10.1111/1440-1681.12935. Epub 2018 Apr 25.
2
Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy.手足皮肤反应随索拉非尼累积剂量以及联合抗血管内皮生长因子治疗而增加。
Clin Cancer Res. 2009 Feb 15;15(4):1411-6. doi: 10.1158/1078-0432.CCR-08-1141.